218 related articles for article (PubMed ID: 27813286)
1. CRISPR/Cas9 Editing of Murine Induced Pluripotent Stem Cells for Engineering Inflammation-Resistant Tissues.
Brunger JM; Zutshi A; Willard VP; Gersbach CA; Guilak F
Arthritis Rheumatol; 2017 May; 69(5):1111-1121. PubMed ID: 27813286
[TBL] [Abstract][Full Text] [Related]
2. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
3. Site-Specific Genome Engineering in Human Pluripotent Stem Cells.
Merkert S; Martin U
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347935
[TBL] [Abstract][Full Text] [Related]
4.
Farhang N; Brunger JM; Stover JD; Thakore PI; Lawrence B; Guilak F; Gersbach CA; Setton LA; Bowles RD
Tissue Eng Part A; 2017 Aug; 23(15-16):738-749. PubMed ID: 28095751
[TBL] [Abstract][Full Text] [Related]
5. Streamlined, single-step non-viral CRISPR-Cas9 knockout strategy enhances gene editing efficiency in primary human chondrocyte populations.
Ponta S; Bonato A; Neidenbach P; Bruhin VF; Laurent A; Applegate LA; Zenobi-Wong M; Barreto G
Arthritis Res Ther; 2024 Mar; 26(1):66. PubMed ID: 38468277
[TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Mesenchymal Stem Cell-Based Engineered Cartilage Ameliorates Polyglycolic Acid/Polylactic Acid Scaffold-Induced Inflammation Through M2 Polarization of Macrophages in a Pig Model.
Ding J; Chen B; Lv T; Liu X; Fu X; Wang Q; Yan L; Kang N; Cao Y; Xiao R
Stem Cells Transl Med; 2016 Aug; 5(8):1079-89. PubMed ID: 27280797
[TBL] [Abstract][Full Text] [Related]
7. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
10. Correction of Hirschsprung-Associated Mutations in Human Induced Pluripotent Stem Cells Via Clustered Regularly Interspaced Short Palindromic Repeats/Cas9, Restores Neural Crest Cell Function.
Lai FP; Lau ST; Wong JK; Gui H; Wang RX; Zhou T; Lai WH; Tse HF; Tam PK; Garcia-Barcelo MM; Ngan ES
Gastroenterology; 2017 Jul; 153(1):139-153.e8. PubMed ID: 28342760
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach.
Kafienah W; Al-Fayez F; Hollander AP; Barker MD
Arthritis Rheum; 2003 Mar; 48(3):709-18. PubMed ID: 12632424
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs.
Morishige S; Mizuno S; Ozawa H; Nakamura T; Mazahery A; Nomura K; Seki R; Mouri F; Osaki K; Yamamura K; Okamura T; Nagafuji K
Int J Hematol; 2020 Feb; 111(2):225-233. PubMed ID: 31664646
[TBL] [Abstract][Full Text] [Related]
13. Step-Wise Chondrogenesis of Human Induced Pluripotent Stem Cells and Purification Via a Reporter Allele Generated by CRISPR-Cas9 Genome Editing.
Adkar SS; Wu CL; Willard VP; Dicks A; Ettyreddy A; Steward N; Bhutani N; Gersbach CA; Guilak F
Stem Cells; 2019 Jan; 37(1):65-76. PubMed ID: 30378731
[TBL] [Abstract][Full Text] [Related]
14. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the use of induced pluripotent stem cells (iPSCs) for the regeneration of tracheal cartilage.
Imaizumi M; Nomoto Y; Sato Y; Sugino T; Miyake M; Wada I; Nakamura T; Omori K
Cell Transplant; 2013; 22(2):341-53. PubMed ID: 22863018
[TBL] [Abstract][Full Text] [Related]
16. Successful correction of factor V deficiency of patient-derived iPSCs by CRISPR/Cas9-mediated gene editing.
Nakamura T; Morishige S; Ozawa H; Kuboyama K; Yamasaki Y; Oya S; Yamaguchi M; Aoyama K; Seki R; Mouri F; Osaki K; Okamura T; Mizuno S; Nagafuji K
Haemophilia; 2020 Sep; 26(5):826-833. PubMed ID: 32700411
[TBL] [Abstract][Full Text] [Related]
17. Genome-Edited Human Pluripotent Stem Cell-Derived Macrophages as a Model of Reverse Cholesterol Transport--Brief Report.
Gupta RM; Meissner TB; Cowan CA; Musunuru K
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):15-8. PubMed ID: 26543098
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal Stem Cell Engineering.
Liu S
Methods Mol Biol; 2018; 1868():145-150. PubMed ID: 30244462
[TBL] [Abstract][Full Text] [Related]
19. Engineered Cartilage from Human Chondrocytes with Homozygous Knockout of Cell Cycle Inhibitor p21.
D'Costa S; Rich MJ; Diekman BO
Tissue Eng Part A; 2020 Apr; 26(7-8):441-449. PubMed ID: 31642391
[TBL] [Abstract][Full Text] [Related]
20. Genome Engineering of Stem Cells for Autonomously Regulated, Closed-Loop Delivery of Biologic Drugs.
Brunger JM; Zutshi A; Willard VP; Gersbach CA; Guilak F
Stem Cell Reports; 2017 May; 8(5):1202-1213. PubMed ID: 28457885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
